Johnson & Johnson

NYSE:JNJ   3:59:59 PM EDT
172.20
+0.02 (+0.01%)
5:23:00 PM EDT: $172.53 +0.33 (+0.19%)
Products

FDA Says Authorized Use For Janssen Covid-19 Vaccine Of Additional Batch Of Vaccine Drug Substance Manufactured At Emergent Facility

Published: 06/15/2021 22:52 GMT
Johnson & Johnson (JNJ) - FDA Says Authorized Use, Under Eua for Janssen Covid-19 Vaccine, of Additional Batch of Vaccine Drug Substance Manufactured at Emergent Facility.
FDA Says Not Yet Ready to Include the Emergent Biosolutions Plant in Janssen Eua As an Authorized Manufacturing Facility.
((reuters.
Briefs@thomsonreuters.
Com;)).